Abstract Bronchial asthma (BA) is a common chronic inflammatory disease characterized by hyperresponsive airways, excess mucus production, eosinophil activation, and the production of IgE. The complement system plays an immunoregulatory role at the interface of innate and acquired immunities. Recent studies have provided evidence that C3, C3a receptor, and C5 are linked to airway hyperresponsiveness. To determine whether genetic variations in the genes of the complement system affect susceptibility to BA, we screened single nucleotide polymorphisms (SNPs) in C3, C5, the C3a receptor gene (C3AR1), and the C5a receptor gene (C5R1) and performed association studies in the Japanese population.
Introduction
The incidence of allergic diseases has significantly increased over the past few decades. These allergies are complex conditions caused by a combination of genetic and environmental factors (Barnes and Marsh 1998) . Bronchial asthma (BA) is an allergic condition characterized by three key phenotypes: intermittent airway obstruction, inflammatory cell infiltrates, and airway hyperresponsiveness (AHR) (Daser et al. 2001) , which are all closely linked to Th2 lymphocyte functions.
The complement system defends the host from invading microorganisms by initiating inflammatory and immunological responses and by promoting cell lysis (Barrington et al. 2001; Kohl 2001; Muller-Eberhard 1988) . Complement activation leads to the production of several fragments; among these, anaphylatoxins (including C3a and C5a) can stimulate respiratory burst in macrophages, and Gerard 2002) . The anaphylatoxins C3a and C5a causes histamine release from basophils and mast cells (Burgi et al. 1994; el-Lati et al. 1994) , exhibit properties resembling IgE-mediated anaphylaxis, contract smooth muscle, activate mast cells, and increase vascular permeability (Henson 2000) .
Recent studies indicate that the complement system plays an important role in the pathogenesis of BA. Mice and guinea pigs that are deficient for the C3a receptor (C3aR) are protected against bronchoconstriction and AHR that develops after allergen challenges (Bautsch et al. 2000; Drouin et al. 2002; Humbles et al. 2000) . Mice deficient in C3 or C3aR have decreased AHR and lung eosinophilia after allergen challenges (Drouin et al. 2001a ). On the other hand, strains of mice that are naturally deficient in C5 have increased susceptibility to allergen-induced AHR via decreased IL-12 production (Karp et al. 2000) . These animal studies suggest that C3a and C5a have opposite effects. Both C3a and C5a levels are increased in the bronchoalveolar lavage fluid of patients with BA after allergen provocation compared with healthy control individuals (Humbles et al. 2000; Krug et al. 2001; van de Graaf et al. 1992) , suggesting that the C3 and C5 pathways are involved in human BA.
Several genome-wide screens for susceptibility to BA and atopy have identified candidate loci, including chromosomes 9q32- 34 and 19q13.3-q13.4 , where C5 and the gene encoding the C5a receptor (C5R1) are respectively localized (CSGA 1997; Ober et al. 1998; Wjst et al. 1999) .
Clinical, experimental, and genetic evidence suggests that genes involved in the C3 and C5 pathways are strong candidates for BA susceptibility genes. We therefore screened SNPs in C3, C5, C3AR1 (encoding C3aR) and C5R1, and performed association studies of clinically characterized Japanese patients with childhood or adult BA.
Materials and methods

Subjects
In this study, we classified patients who were under 17 years of age at entry as having childhood BA and those who were 18 years of age or older as having adult BA regardless of the age of onset. We recruited 384 patients with childhood BA and 96 patients with adult BA from Osaka Prefectural Habikino Hospital and 384 patients with adult BA from the Miyatake Asthma Clinic. All participants with BA were selected according to the American Thoracic Society criteria (National Heart, Lung, and Blood Institute 1991). The patients with childhood BA had a mean age of 9.8 years (range, 1-17 years). The patients with adult BA had a mean age of 45.9 years (range, 18-83 years). The mean onset of childhood BA was 3.3 years. Of the patients with adult BA, 22% showed onset under 18 years old. Total serum IgE level and eosinophil count were measured from blood samples for genetic analyses. The mean of log 10 [total IgE (tIgE) (IU/ ml)] of patients with childhood BA was 2.59; that of patients with adult BA was 2.32. The mean of log 10 [-eosinophil count (percentage of white blood cells)] in patients with childhood BA was 0.77; that of patients with adult BA was 0.66. In this study, "high IgE" levels were defined as those values in the 75th percentile or higher of total IgE. The 75th percentile value of log 10 (tIgE) in patients with childhood BA was 3.04 [=log 10 (1,092 IU/ ml)]. That in patients with adult BA was 2.68 [=log 10 (480 IU/ml)]. In adult patients, we also examined the presence of first-to third-degree relatives with BA (positive: 54%), aspirin-induced BA (history of at least two attacks due to aspirin or related drugs; positive: 5.6%), and nasal polyps (positive: 13%). The severity of adult BA was classified according to the criteria of the National Heart, Lung, and Blood Institute (1997) by physicians who are experts in allergic diseases. The severity of childhood BA was defined according to the degree of therapy required to control symptoms at the time of entry into this study. The grades were as follows: grade 1, β stimulants only; grade 2, sodium cromoglycate and/or theophylline; grade 3, inhaled beclomethasone, 400 μg/ day or less; grade 4, inhaled beclomethasone of more than 400 μg/day. Patients with grades 3 and 4 were treated with inhaled steroids and they accounted for 46% of all patients. We also examined the number of parents of the proband who also had BA, the number of siblings with BA, and the level of IgE specific for house dust mites in the patients with childhood BA. Specific IgE was considered positive when values exceeded 0.35 U A /ml (RAST score ≥1) according to an enzyme immunoassay. Atopy was defined as positive mite-specific IgE. Of the patients with childhood BA, 80% had atopic BA. Atopic dermatitis was observed in 45% of the patients with childhood BA. Of the patients with childhood BA, 26% had a parent with BA. As controls, we analyzed 384 randomly selected population-based individuals (mean age 41.5; range, 18-81 years; male/female ratio=2.05:1.00) who had no history of BA.
Peripheral blood was sampled for genetic analyses. We screened SNPs using cDNA synthesized from the mRNAs of 12 volunteers. We used standard procedures to obtain mRNA and synthesize cDNA, as well as to prepare genomic DNAs for SNP genotyping. All patients and volunteers provided written informed consent to participate in the study in accordance with the rules of the process committee at the SNP Research Center (RIKEN).
SNP screening and genotyping
We designed specific primer sets based on the C3, C5, C3AR1, and C5R1 cDNA sequences in the GenBank DNA database (accession numbers K02765, M57729, U62027 and M62505, respectively) to screen their entire coding regions. We first amplified 40 ng of cDNA from 12 individuals by the polymerase chain reaction (PCR) method. Information on the primers and reaction condi-tions of PCR will be provided on request. Each amplification product was reacted with BigDye Terminator RR mix (Applied Biosystems, Foster City, Calif., USA) using the same primers as for the PCR amplification, and then sequences were determined using an ABI Prism 3700 DNA autosequencer (Applied Biosystems). Sequences were analyzed with SEQUENCHER 3.1 software (Gene Codes, Ann Arbor, Mich., USA).
We genotyped single-nucleotide polymorphisms (SNPs) by PCR-directed sequencing or by PCR-restriction fragment length polymorphism (PCR-RFLP) analysis. Specific primers were designed based on genomic sequences containing these genes obtained from the GenBank DNA database (accession numbers AC008760 in C3, AC006430 in C5, AC006511 in C3AR1, and AC099491 in C5R1). Information on the primer sequences and thermal cycling conditions will be provided on request. We genotyped all SNPs by direct sequencing, except C5 1632T/C, which was genotyped by the PCR-RFLP method. The PCR product for C5 1632T/C was digested with RsaI at 37°C. Digested PCR fragments were resolved by electrophoresis on 4% agarose gels.
Statistical analysis
Serum IgE levels and eosinophil counts were log 10 -transformed before analysis. The contingency chi-square test compared allele frequencies in patients with BA and controls. In the association study between individual SNPs and asthma or a BA-related phenotype, we performed many statistical tests; therefore, inflation of false positive results (type 1 error) was a concern. Because all SNPs in each gene were significantly in linkage disequilibrium and because asthma-related phenotypes (seven variables for children and seven variables for adults, see Results) are significantly related, multiplication of P values by the number of SNPs or phenotypes tested is too conservative and the appropriate value for the correction is not evident. Thus, to deal with the multiple comparisons, we did not apply Bonferroni corrections but set the significant P value at 0.01 rather than 0.05. Odds ratios were estimated according to Brown (1981) . Haplotypes were analyzed with a maximum-likelihood method using ARLEQUIN software Ver. 2.0 (Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, Geneva, Switzerland) (Excoffier and Slatkin 1995) . The program HAPLOTYPER (http://www.people.fas.harvard. edu/~junliu/Haplo/docMain.htm) determined the most probable haplotype and diplotype in individuals with uncertain genotype phases (Niu et al. 2002) . Haplotype frequencies between patients and controls were evaluated both by the entire distribution with Fisher's exact test and by chi-square tests of one haplotype against others (haplotype-wise test). In this test, probability values were corrected for multiple comparisons by multiplying the P value by the number of haplotypes compared. Effects of genotypes or haplotypes on log 10 -transformed IgE levels and eosinophil counts were evaluated using the analysis of variance (ANOVA) or t-test. Statistical analyses were performed with SPSS software, version 11.0J (SPSS Japan, Tokyo, Japan), unless otherwise noted.
Results
Polymorphisms in the complement system genes
Complements and their receptor genes were screened for variations in 12 Japanese individuals. From the screening of cDNA sequences, we identified nine SNPs in the C3 gene, five SNPs in the C5 gene, three SNPs in the C3AR1 gene, and two SNPs in the C5R1 gene. Seven SNPs of C3 (912G/A: rs3815752, 1692G/A: rs3745559, 1836G/A: rs3745560, 2421C/G: rs428453, 2745C/T: rs423490, 4311C/T: rs11569554, 4896C/T: rs4807893) were already registered in the dbSNP database (http://www.ncbi.nlm. nih.gov/SNP/). Two (1872CT and 2811A/T) were not confirmed at the genomic DNA level and not investigated further. In the C5 gene, four SNPs (1155A/G: rs10985126, 1632C/T: rs25681, 2404A/G: rs17611, 4266G/A: rs12237774) were found in the dbSNP and one SNP (433G/A: ss23140500) was not. All three SNPs (210C/T: rs11567805, 1526G/A: rs2230318, 1595A/G: rs7842) in C3AR1 were found in the dbSNP. The two SNPs we identified in the C5R1 were new (1289C/A ss23141118, 1337C/T: ss23141119). Among 17 SNPs identified in the four genes, two were non-synonymous substitutions [C5 433G/A (Val145Ile), C5 2404A/G (Ile802Val)], four were located in the 3′-untranslated regions (C3AR1 1526G/A and 1595A/G, C5R1 1289C/A and 1337C/T), and the rest were synonymous substitutions. Thirteen SNPs (C3: 912G/A, 1692G/A, 1836G/A, 4896C/T; C5: 433G/A, 1155A/G, 1632C/T, 2404A/G, 4266G/A; C3AR1: 1526G/ A, 1595A/G; C5R1: 1289C/A, 1337C/T) were used for the association studies.
Association of SNPs with bronchial asthma
We genotyped 384 patients with childhood BA, 480 patients with adult BA, and 384 controls. The cohort represents the largest number of samples among published genetic studies of BA in Japanese patients. All genotype results of the SNPs in the control samples were in HardyWeinberg equilibrium, except C5 4266G/A. All control samples were retyped by the TaqMan PCR method (Fujii et al. 2000) . The result was consistent with that by the sequencing method, suggesting no indication of typing errors with this SNP. In the association study of childhood BA, we stratified patient data by age at onset, high total IgE level, mite-specific IgE (atopy), high eosinophil count, severity, existence of atopic dermatitis, and family history. In the study of adult BA, we stratified patient data by age at onset, high total IgE level, eosinophil count, severity, aspirin-induced asthma, nasal polyps, and family history. Table 1 shows the results of the case-control study, where P values of association of the SNPs with patients with BA with and without data stratification were no more than 0.010 in genotypic association tests. When all patients were examined, only the association of C3 4896C/T with adult BA was marginally significant (odds ratio=1.53, CI=1.11-3.59, P=0.010). We next performed association studies of patients stratified by the BA-related phenotypes. Association between C3 4896C/T and BA was evident in childhood BA with atopy (P=0.0078), or with severity ≥3 (P=0.0041). This SNP and adult BA with high total IgE (≥480 IU/ml) were also associated (P=0.0016). An association between C3AR1 1526G/A and the patients with the most severe cases of childhood BA was suggested (P=0.0050).
We next investigated associations between BA-related phenotypes and SNPs within patients with BA (case-only association study). With this method, spurious associations can be avoided due to population stratification (Khoury 1998; Reich and Goldstein 2001) . Table 1 also includes results of the case-only study. The 1526G/A of C3AR1 was associated with the severity of childhood BA (P=0.0057). The 1595G/A of C3AR1 was associated with the existence of atopic dermatitis in childhood BA (P=0.0092). The 1632C/T and 2404G/A of C5 were associated with onset of adult BA to a similar degree because these SNPs are in strong linkage disequilibrium (P=0.0053 and P=0.0054, respectively).
There was no significant association between SNPs in the C5R1 gene and BA. An evaluation of total IgE level and eosinophil count by ANOVA did not reveal any significant differences among the studied SNP genotypes. Association of haplotypes of the C3 and C5 genes with BA
We estimated the frequencies of the C3 and C5 gene haplotypes using an expectation-maximization algorithm (Excoffier and Slatkin 1995) . Table 2 shows that the distribution of the C3 haplotype frequency differed between the control and childhood BA (P=0.0078) and between the control and adult BA (P=0.00016). The most frequent haplotype in controls was 912G, 1692A, 1836G, and 4896C (GAGC), whereas the 912G, 1692A, 1836G, and 4896T (GAGT) haplotype was the most frequent in asthmatics. The frequency of the GAGC haplotype in the adult patients was significantly lower (χ 2 =18.62, P=0.00011, odds ratio=0.58, CI=0.45-0.75) than that in the controls. The GAGT haplotype was significantly associated with both types of asthmatics (χ 2 =15.47, P=0.0021, odds ratio=1.55, CI=1.22-1.97 for childhood BA; χ 2 =11.18, P=0.0058, odds ratio=1.48, CI=1.18-1.86 for adult BA). There is a concern about the accuracy of the haplotype frequency results because we used inferred haplotypes when they could not be determined unambiguously. Thus we analyzed only samples whose certainty of haplotype was more than 0.99. The number of such alleles in controls was 510; the number in cases of childhood BA was 430; and in cases of adult BA was 538. All the differences mentioned above with all samples remained highly significant with the phase-certain samples (not shown).
Powerful evidence indicated that the C5 haplotype is also associated with childhood and adult BA (Table 2 ). In comparison with the overall distribution, the P values of association for childhood BA was 2.0×10 −6 and that for adult BA was 0.0021. The major difference resided in the frequency of the 433G, 1155G, 1632C, 2404G, and 4266A (GGCGA) haplotype. The frequency of this haplotype in the control population was 5.7%, whereas it was 0.55% in childhood BA (χ 2 =27.16, P=1.3×10
, odds ratio=0.10, CI=0.035-0.29) and 1.5% in adult BA (χ 2 =15.38, P=0.00062, odds ratio=0.25, CI=0.12-0.53). The results suggested that the GGCGA haplotype of C5 is an allele that protects against the disease. Again, the differences in the overall distribution and GGCGA haplotype of C5 remained highly significant with the phase-certain samples (not shown).
Discussion
Because the genes in the complement system are promising candidates for the pathogenesis of BA, we systematically screened all exons of the C3, C5, C3AR1, and C5R1 genes for common polymorphisms and performed case-control and case-only association studies of clinically characterized patients.
Among the SNPs in C3, only 4896C/T was weakly associated with BA. This association became evident when patient data were stratified by total IgE, atopy, or severity ( Table 1 ). Given that high total IgE was related to higher severity, the primary target of the effect of C3 variations is thus difficult to define. The C3 gene may affect the total IgE level through Th2 effector functions or it may directly affect the late phase of airway inflammation. Evidence that C3 is associated with BA is further supported by the results of the haplotype analysis. The frequency of the GAGT haplotype was significantly higher in childhood and in adult BA patients than in controls. The distribution of the haplotype frequency in the BA patients also differed from that of controls. The different haplotypes of the C3 gene do not alter the amino acid sequence of C3 protein. It is therefore unlikely that this combination of nucleotide polymorphisms per se affects the function of C3. The nucleotide changes that are in linkage disequilibrium with this haplotype must exist in a part of the C3 gene that we have not yet investigated. We are currently screening polymorphisms in the promoter region and introns of the C3 gene to identify variations that might affect the gene expression.
The 1526G/A of the C3AR1 was associated with the severe childhood BA in the case-control study. The results of the case-only association study supported the result of the case-control study. The group of patients with a milder condition can be regarded as controls in the case-only analysis. The C3AR1 gene may be related with severity of childhood BA or with the severest childhood BA.
The case-control study showed that C3 4896C/T was associated with atopic childhood BA. The case-only study showed that C3AR1 1595A/G was associated with atopic dermatitis in patients with childhood BA. Because atopy and atopic dermatitis are strongly correlated, the C3 pathway might also be involved in the development of atopy or atopic dermatitis, at least in patients with childhood BA.
Two SNPs of the C5 gene, 1632C/T and 2404A/G, were associated with onset of adult BA. We examined only whether childhood BA (onset <18 years old) was recorded among the patients with adult BA. Detailed data on the onset of adult BA should be collected to confirm the association of the age of onset and C5 SNPs.
Among haplotypes in the C5 gene, GGCGA was associated with both childhood BA and adult BA. The frequencies of this haplotype in the patient groups were significantly lower than that in the control group, suggesting that it protects against the development of BA. The 433G and 2404G haplotypes of the C5 gene resulted in valine at 145 and 802 of the amino acid sequence of C5. This Val145-Val802 type of C5 was not thought to directly reduce the risk of disease because the GACGG and GGCGG haplotypes that also produce the same C5 protein did not reduce the risk. As in C3, this haplotype of the C5 gene is probably in linkage disequilibrium with unidentified functional nucleotide changes. Nevertheless, the GGCGA haplotype is a good marker of the allele that protects against BA. Compared with what is known about the C3 pathway, less is known about the mechanism of C5 in the development of BA. The production of IL-12 from macrophages is reduced in mice that are deficient in C5 (Karp et al. 2000) . Given that IL-12 is a cytokine that drives the CD4 + Th1 immune response, a deficiency of IL-12 would result in Th2 dominant responses. Exogenous IL-12 prevents airway hyperresponsiveness in ovalbumin-susceptible strains (Gavett et al. 1995) . Thus, whether cells of the immune systems of individuals with the GGCGA haplotype produce more C5 and IL-12 should be investigated.
In conclusion, we have discovered evidence for the association of particular haplotypes of the C3 and C5 genes with the development of BA in the Japanese population. Our data also suggested that the C3AR1 gene also affects disease severity. This is the first report to describe associations between SNPs of genes in the C3 and C5 pathways and BA in humans. Because the identified SNPs and haplotypes are probably markers for true susceptibility changes in the genes, we intend to extend our survey of polymorphisms in the promoter regions as well as introns of the genes. A significant association between promoters and intronic variants of genes and diseases has been reported (Niimi et al. 2002; Prokunina et al. 2002) . Further investigations of other populations, and of alterations in gene function due to polymorphisms, are also required to establish the effect of the complement system on the pathogenesis of BA.
